Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-20
1997-09-16
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514307, 514318, 514321, 514322, 514323, 514324, 514326, 514367, 514372, 514373, 514375, 514378, 514379, 514394, 514406, 546139, 546167, 546193, 546194, 546196, 546197, 546198, 546199, 546201, 546202, 546205, 546211, 548152, 548159, 548206, 548207, 548217, 548241, 548247, 5483061, 5483611, 5483641, 5483644, 5483657, A61K 3147, A61K 31415, A61K 3142, A61K 31425, A61K 31445, C07D40104, C07D40904
Patent
active
056681488
ABSTRACT:
Compounds that specifically bind to the human alpha1a adrenergic receptor, including compounds effective to reduce symptoms of benign prostatic hypertrophy include compounds of formula: ##STR1## wherein: Ar1 and Ar2 can be independantly aromatic, heteroaromatic, or condensed heteroaromatic unsubstituted or substituted with amino, alkoxy, sulfonamido, alkyl, heteroalkyl, halo;
REFERENCES:
patent: 5403847 (1995-04-01), Gluchowski et al.
Metcalf BW, Levy MA, Holt DA, TIPS 10, pp. 490-495. Dec. 1989.
Payne Linda S.
Young Steven D.
Zaborowski Mary Jo L.
Appollina Mary A.
Huang Evelyn
Ivy C. Warren
Merck & Co. , Inc.
Winokur Melvin
LandOfFree
Alpha1a adrenergic receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha1a adrenergic receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha1a adrenergic receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218559